Healthcare provider profile · identity verified

Acadia Pechauer, MD

Internal Medicine · TUCSON, AZ · NPI 1083277941

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	257	89
Amlodipine Besylate	Amlodipine Besylate	184	63
Lisinopril	Lisinopril	141	55
Losartan Potassium	Losartan Potassium	117	37
Gabapentin	Gabapentin	110	33
Levothyroxine Sodium	Levothyroxine Sodium	97	34
Fluticasone Propionate	Fluticasone Propionate	80	32
Metformin Hcl Er	Metformin Hcl	77	26
Trulicity	Dulaglutide	77	14
Omeprazole	Omeprazole	76	28
Albuterol Sulfate Hfa	Albuterol Sulfate	68	32
Trazodone Hcl	Trazodone Hcl	66	22
Metoprolol Succinate	Metoprolol Succinate	60	17
Oxycodone Hcl	Oxycodone Hcl	59	11
Metformin Hcl	Metformin Hcl	55	22
Diphenhydramine Hcl	Diphenhydramine Hcl	53	suppressed
Furosemide	Furosemide	52	17
Duloxetine Hcl	Duloxetine Hcl	49	19
Carvedilol	Carvedilol	48	15
Famotidine	Famotidine	48	15
Jardiance	Empagliflozin	48	17
Eliquis	Apixaban	47	11
Glipizide Er	Glipizide	47	16
Pantoprazole Sodium	Pantoprazole Sodium	44	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	43	17
Tamsulosin Hcl	Tamsulosin Hcl	43	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	11
Ozempic	Semaglutide	39	suppressed
Alendronate Sodium	Alendronate Sodium	37	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	12
Hydroxyzine Hcl	Hydroxyzine Hcl	32	14
Naproxen	Naproxen	32	suppressed
Mirtazapine	Mirtazapine	31	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	30	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	15
Glipizide	Glipizide	28	12
Potassium Chloride	Potassium Chloride	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	11
Hydrochlorothiazide	Hydrochlorothiazide	23	suppressed
Ondansetron Hcl	Ondansetron Hcl/Pf	23	suppressed
Sertraline Hcl	Sertraline Hcl	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	22	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Baclofen	Baclofen	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Mounjaro	Tirzepatide	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	15	13
Xtampza Er	Oxycodone Myristate	15	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Prednisone	Prednisone	14	13
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Estradiol	Estradiol	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Humulin N	Insulin Nph Human Isophane	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Linzess	Linaclotide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error